What analyst ratings and price targets actually tell you
Sell side analysts publish two things about a stock: a rating, which is a word, and a price target, which is a number. Both are widely reported and widely misread. This guide explains what each one is, what the changes in them mean, and how to use the whole set of analysts covering a name rather than any one of them.
What a rating is
A rating is a firm's summary view, expressed in that firm's own scale. Buy, Outperform, Overweight and Strong Buy are all positive ratings from different houses; Hold, Neutral, Market Perform and Equal Weight are all middle ratings; Sell, Underperform and Underweight are negative. The words are not comparable across firms, which is why FundSpec groups them into bullish, neutral and bearish when it counts positioning.
Ratings skew positive. Far more stocks carry a Buy than a Sell, for reasons that have to do with how research is paid for and how access to companies is maintained. A Hold from a firm that rarely issues Sells can be a quietly negative view. The scale matters more than the word.
What a price target is
A price target is where the analyst expects the stock to trade over a stated horizon, usually twelve months, if their thesis plays out. It is a model output, and the model's inputs are the analyst's forecasts of revenue, margins and multiples. When those forecasts change, the target changes.
Targets are more informative than ratings because they are numbers and can be compared. The median target across all covering analysts is a reasonable summary of where the sell side thinks the stock should trade. The distance between that median and the current price is the implied upside or downside, and FundSpec ranks stocks on exactly that.
Changes carry more information than levels
A rating on its own is a stale opinion of unknown age. A change is news. An upgrade or a downgrade means an analyst has reviewed the thesis and moved, and the direction of the move is a fresh signal about what they have learned. An initiation is a firm deciding the stock is worth covering, which is itself a statement about interest. A reiteration with a raised target is a mild positive; a reiteration with a cut target after an earnings miss is often the first step towards a downgrade.
Read the change together with the previous rating. A move from Sell to Hold is a bigger shift in view than a move from Buy to Strong Buy, even though the second sounds more exciting.
Dispersion is the signal most people skip
The average rating tells you what the sell side thinks. The spread tells you how sure it is. When every analyst carries a Buy with targets within a few percent of each other, the consensus is settled and the stock is priced for it. When ratings run from Sell to Strong Buy and targets range across a factor of two, the analysts are looking at the same filings and reaching opposite conclusions. Those are the battleground stocks, and they are where the next piece of information moves the price most.
FundSpec lists the battleground names separately for that reason. They are not necessarily good or bad; they are the names where the argument is still open.
Where analysts are useful and where they are not
Analysts are good at the facts. Their estimates for revenue and earnings are the consensus that earnings surprises are measured against, and their notes often contain the clearest available explanation of a company's segments and drivers. They are less reliable at timing, and their targets follow prices more often than they lead them: a stock that has rallied collects target increases, a stock that has fallen collects cuts.
The most useful reading is therefore not "analysts are bullish, so buy" but "analysts have moved, and here is what they now believe the numbers will be". The next earnings report tests that belief, and the surprise against consensus is where the market reacts.
How FundSpec shows it
The Analyst Ratings screen has six lists: the most widely covered stocks, the names with the most bullish and most bearish analyst positioning, the largest implied upside and the largest implied downside against the median target, and the battleground stocks with the widest disagreement. Each rating change shows the firm, the previous and current rating and the price target. Every stock page carries its own analyst tab with the full history of actions and the low, average and high targets, and subscribers can set an alert for rating changes on the names they hold.
Put this to work in the FundSpec web app. The same screen is in the iOS and Android apps.
Open Analyst Ratings